We recently showed that five out of 479 melanoma patients harbor MAPK7 missense mutations, including P789S and A424S, two potential phosphorylation targets of C-terminus worth being characterized for their possible impact on ERK5 nuclear shuttling [88]. Here, MAPK7 is linked to melanoma.